Zobrazeno 1 - 10
of 70
pro vyhledávání: '"B S Kibrik"'
Autor:
O G Chelnokova, B S Kibrik
Publikováno v:
Терапевтический архив, Vol 78, Iss 3, Pp 32-36 (2003)
Aim. To specify diagnostic approaches to rapidly progressive destructive pulmonary tuberculosis (RPDPT) in general hospitals and effects of the time of the diagnosis on treatment results. Materials and methods. History, diagnostic techniques and trea
Externí odkaz:
https://doaj.org/article/2ffef81eb29742e5a8103b9f44867d49
Publikováno v:
Антибиотики и Химиотерапия, Vol 57, Iss 11-12, Pp 16-21 (2020)
Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide (MSH) registered in Russia under the name of tubosan of the class of immunotropic agents were investigated with the use of 78 clinical isolates of Mycobacter
Externí odkaz:
https://doaj.org/article/7b43c320b9d0440fa2edfc381389b758
Publikováno v:
Антибиотики и Химиотерапия, Vol 58, Iss 11-12, Pp 23-25 (2020)
Resistance of Mycobacterium tuberculosis isolated from new cases registered during a period from 2007 to 2012 was estimated. High rate of the M.tuberculosis multiple drug resistance increase was observed: from 28% in 2007 to 64% in 2012. Low efficacy
Externí odkaz:
https://doaj.org/article/46146ae3fc5742d09a6576edf082cacf
Publikováno v:
Туберкулез и болезни лёгких, Vol 95, Iss 6, Pp 51-58 (2017)
Goal of the study: to investigate the impact of isoniazid combined with silver nanoparticles on the isoniazid resistant strains of tuberculous mycobacteria and the course of experimental of tuberculosis caused by the above strains.Materials and metho
Externí odkaz:
https://doaj.org/article/d2a5ce84981b42a4910e47390eaa2cb5
Publikováno v:
Bulletin of Experimental Biology and Medicine. 156:255-259
We analyzed mutagenic and mitosis-modifying effects of silver nanoparticles (Allium test). Chromosome aberrations and laggings and micronuclei were simultaneously registered in the same sample. Mitotic and phase indexes were calculated. No mutagenic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d79474459693e585b6d4a8e4de42505
https://doi.org/10.1007/s10517-013-2325-8
https://doi.org/10.1007/s10517-013-2325-8
Publikováno v:
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 58(11-12)
Resistance of Mycobacterium tuberculosis isolated from new cases registered during a period from 2007 to 2012 was estimated. High rate of the M.tuberculosis multiple drug resistance increase was observed: from 28% in 2007 to 64% in 2012. Low efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::29bcfd51b448323e9842a16d38cfbbec
https://pubmed.ncbi.nlm.nih.gov/24734425
https://pubmed.ncbi.nlm.nih.gov/24734425
Publikováno v:
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 57(11-12)
Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide (MSH) registered in Russia under the name of tubosan of the class of immunotropic agents were investigated with the use of 78 clinical isolates of Mycobacter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8b3b89313ef8e443e93c33bd5d31fecd
https://pubmed.ncbi.nlm.nih.gov/23700932
https://pubmed.ncbi.nlm.nih.gov/23700932
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 76(2)
The antituberculosis effect of tubosan registered in the Russian Federation as an immunostimulant drug has been studied on a series of 53 clinical strains of Mycobacterium tuberculosis (MBT). It is established that tubosan produces a bactericidal eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a86440b502020f52c71aa7b599a1a05
https://pubmed.ncbi.nlm.nih.gov/23631279
https://pubmed.ncbi.nlm.nih.gov/23631279
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 74(4)
The antituberculous activity of a nanocomposite based on nanoparticulate silver and isoniazid has been studied on the model of drug-resistant tuberculosis in a group of 65 white mice. The possibility of overcoming the resistance of the tuberculosis a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a17ca1c1c4039964699c45a545789781
https://pubmed.ncbi.nlm.nih.gov/21678655
https://pubmed.ncbi.nlm.nih.gov/21678655
Publikováno v:
Problemy tuberkuleza i boleznei legkikh. (5)
The efficiency of combined treatment with retrosternal lymphotropic administration of drugs and pneumoperitoneum was comparatively analyzed in 148 new cases of destructive pulmonary tuberculosis. Both methods were applied during combined chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db7058403b4f86cf743af4a63d05aa2a
https://pubmed.ncbi.nlm.nih.gov/19565808
https://pubmed.ncbi.nlm.nih.gov/19565808